- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1432-0428
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Cardiovascular outcome trials of glucose-lowering medications: an update ; day:3 ; month:1 ; year:2019 ; pages:1-13
Diabetologia ; (3.1.2019), 1-13
- Urheber
-
Home, Philip
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00125-018-4801-1
- URN
-
urn:nbn:de:101:1-2019020820340663174252
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:52 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Home, Philip
- SpringerLink (Online service)
Ähnliche Objekte (12)
Diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies : a meta-analysis based on cardiovascular outcomes trials
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis
Diabetes, bone and glucose-lowering agents: basic biology
How Do the Recent Major Randomized Controlled Trials Inform Best Use of the Novel Glucose-Lowering Agents?
Current Updates in Rectal Infusion of Fluids and Medications
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies : a meta-analysis based on cardiovascular outcomes trials
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis
Diabetes, bone and glucose-lowering agents: basic biology
How Do the Recent Major Randomized Controlled Trials Inform Best Use of the Novel Glucose-Lowering Agents?
Current Updates in Rectal Infusion of Fluids and Medications
Longitudinal associations between use of antihypertensive, antidiabetic, and lipid-lowering medications and biological aging
Diabetes, glucose control, glucose lowering medications, and cancer risk: A 10-year population-based historical cohort
Incretin-based glucose-lowering medications and the risk of acute pancreatitis and malignancies : a meta-analysis based on cardiovascular outcomes trials
Considering Insulin Secretory Capacity as Measured by a Fasting C-Peptide/Glucose Ratio in Selecting Glucose-Lowering Medications
Inverse association between glucose-lowering medications and severe hyponatremia: a Swedish population-based case-control study
Clinical Considerations for Healthcare Provider-Administered Lipid-Lowering Medications
SGLT2i: beyond the glucose-lowering effect
Pharmacogenetics of novel glucose-lowering drugs
Time-resolved trajectory of glucose lowering medications and cardiovascular outcomes in type 2 diabetes: a recurrent neural network analysis
Diabetes, bone and glucose-lowering agents: basic biology
How Do the Recent Major Randomized Controlled Trials Inform Best Use of the Novel Glucose-Lowering Agents?
Current Updates in Rectal Infusion of Fluids and Medications